SuperCitizen

Marijuana remains a Schedule I controlled substance under federal law, the most restrictive category, even as most states have legalized medical use and many have legalized adult recreational use. This federal-state conflict creates ongoing friction in banking, taxation, employment, immigration, and research.

The Justice Department has generally exercised prosecutorial discretion to deprioritize enforcement against state-legal operators. The Department of Health and Human Services recommended in 2023 that cannabis be moved to Schedule III, which would acknowledge accepted medical use; the rescheduling process is ongoing as of early 2024.

Options range from full federal legalization with regulation similar to alcohol, to rescheduling (which keeps federal prohibition but eases research and tax burdens), to leaving the current Schedule I status unchanged. Each has implications for criminal justice, public health, state revenue, and youth access.

Spectrum of framings

How adherents on each side of the conventional left / center / right spectrum frame this issue — written so each camp would recognize the framing as charitable.

left

Most progressives favor full federal legalization with expungement of prior convictions, equity provisions for communities harmed by the drug war, and federal regulation.

center

Centrists generally support rescheduling at minimum, often paired with banking access, state deference, and limited federal regulation rather than full legalization.

right

Conservatives are split. Many defer to states and back banking access; some support full legalization on federalism grounds; others oppose any rollback citing youth and public-health concerns.

Perspectives

Each perspective is presented in terms its advocates would recognize, with the concerns they treat as paramount. None is endorsed.

Legalize-and-regulate advocates

Federal prohibition has failed: cannabis is widely available, enforcement has produced enormous racial disparities, and the federal-state conflict harms patients, businesses, and research. Federal legalization with sensible regulation and equity provisions is overdue.

Racial disparities in past enforcement
Patient and research access
Banking and tax burdens on state-legal businesses

Federalism and banking reformers

Whether to legalize is a state decision. Federal law should accommodate states that have chosen to legalize — banking, taxes, research — and reschedule cannabis to reflect its accepted medical use, without imposing full federal legalization on states that have not.

State sovereignty over drug policy
Banking access for state-legal businesses
Research access through rescheduling

Public-health and youth-protection concerns

Rapid commercialization of high-potency cannabis raises real risks: adolescent brain development, psychosis in vulnerable users, impaired driving, and addiction. The pace of legalization has outrun the evidence base and youth-protection guardrails.

Adolescent use and brain development
High-potency products and psychosis risk
Impaired driving enforcement